2011
DOI: 10.1007/s10337-010-1883-4
|View full text |Cite
|
Sign up to set email alerts
|

HPLC–MS–MS for the Simultaneous Determination of Atorvastatin and Amlodipine in Plasma of Hypertensive Patients

Abstract: Combination drug products containing amlodipine and atorvastatin are widely marketed and used in the treatment of concomitant hypertension and dyslipidemia. A rapid, simple and sensitive high performance liquid chromatography-tandem mass spectrometry (HPLC-MS-MS) method for determination of atorvastatin and amlodipine in plasma of hypertensive patients has been developed and validated to be used for therapeutic drug monitoring. The plasma samples were subjected to methanol protein precipitation. Chromatographi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 16 publications
0
17
0
Order By: Relevance
“…Therefore, these methods could be useful in daily routine sample handling, when many samples from patients taking different drugs together with HMG-CoA reductase inhibitors are analyzed in clinical laboratories. Recently, several chromatographic methods have been developed for the quantification of statin drugs in combination with other drugs, most of them are commonly used in treatment of cardiovascular disease: atenolol, spironolactone, glibenclamide [61], metoprolol succinate [72], valsartan and chlorthalidone [76,87], timolol maleate, diclofenac sodium [81], fenofibric acid [85], ezetimibe [91], ceftriaxone [92], acetylsalicylic acid [94], amlodipine [98] and losartan, atenolol, acetylsalicylic acid [99].…”
Section: Pharmacokinetic Studiesmentioning
confidence: 99%
“…Therefore, these methods could be useful in daily routine sample handling, when many samples from patients taking different drugs together with HMG-CoA reductase inhibitors are analyzed in clinical laboratories. Recently, several chromatographic methods have been developed for the quantification of statin drugs in combination with other drugs, most of them are commonly used in treatment of cardiovascular disease: atenolol, spironolactone, glibenclamide [61], metoprolol succinate [72], valsartan and chlorthalidone [76,87], timolol maleate, diclofenac sodium [81], fenofibric acid [85], ezetimibe [91], ceftriaxone [92], acetylsalicylic acid [94], amlodipine [98] and losartan, atenolol, acetylsalicylic acid [99].…”
Section: Pharmacokinetic Studiesmentioning
confidence: 99%
“…In principle, the joint of complementary medicines can not only help to meet the target blood pressure, but also decrease the morbidity and mortality of complications. In practice, many doctors as well as the World Health Organization have been beginning to detector (UV) [10][11][12][13], fluorescence detector (FD) [14,15], amperometric detector (AD) [16], diode array detector (DAD) [17][18][19] and mass spectrometry (MS) [20][21][22]. However, most works have been focused on quantifying a small amount or one kind of antihypertensives in biological matrix or Chinese herbal matrix.…”
Section: Introductionmentioning
confidence: 99%
“…Coupled with Fluorescence Detection [12] Capillary Electrophoresis [3] HPLC Coupled with UV Detection [13][14][15][16][17], HPLC-MS-MS [18][19][20], RP-UPLC [21,22]. Stability testing and stress testing (forced degradation studies) are critical components of drug development strategy.…”
Section: Introductionmentioning
confidence: 99%